G1 Therapeutics, Inc. (G1H.F)
| Previous Close | 3.6260 |
| Open | 3.5580 |
| Bid | 3.6660 x 0 |
| Ask | 3.7660 x 0 |
| Day's Range | 3.5580 - 3.5580 |
| 52 Week Range | 1.0350 - 4.4180 |
| Volume | |
| Avg. Volume | 882 |
| Market Cap | 194.148M |
| Beta (5Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8700 |
| Earnings Date | May 01, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 50.86 |
Simply Wall St.G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit
We feel now is a pretty good time to analyse G1 Therapeutics, Inc.'s ( NASDAQ:GTHX ) business as it appears the company...
GlobeNewswireG1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
RESEARCH TRIANGLE PARK, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will host a webcast and conference call to provide a financial and corporate update for the first quarter of 2024 on Wednesday May 1, 2024, at 8:30 a.m. ET. To register for the event and receive a dial in number and unique PIN to access the live conference call, please follow this link to register online. While not required, it is recommended that you join 1
- GlobeNewswire
G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
RESEARCH TRIANGLE PARK, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Executive Officer Jack Bailey will provide a corporate presentation during the 23rd Annual Needham Virtual Healthcare Conference on Thursday, April 11, 2024, at 8:45 AM ET. The webcast of the event will be accessible on the Events & Presentations page of https://www.g1therapeutics.com/. About G1 TherapeuticsG1 Therapeutics, In
